Medical comorbidities in bipolar disorder (BIPCOM): clinical validation of risk factors and biomarkers to improve prevention and treatment. Study protocol
Giovanni de Girolamo,Ole A. Andreassen,Michael Bauer,Paolo Brambilla,Stefano Calza,Nicholas Citerà,Rosa Corcoy,Andrea Fagiolini,Miguel Garcia-Argibay,Ophélia Godin,Florian Klingler,Nene F. Kobayashi,Henrik Larsson,Marion Leboyer,Silke Matura,Alessandra Martinelli,Víctor De la Peña-Arteaga,Roberto Poli,Andreas Reif,Philipp Ritter,Linn N. Rødevand,Marta Magno,Elisa Caselani,Maximilian Bayas,Frank Bellivier,Narcís Cardoner Álvarez,Pietro Carmellini,Federico Cevoli,Julia Clemens,Philippe Courtet,Lorena Consoli,Giuseppe Delvecchio,Maja Dobrosavljevic,Bruno Etain,Hendrik Friedrichsen,Adrienne Kelemen,Despoina Koukouna,Eugenia Mato,Dídac Mauricio,Romina Miranda-Olivos,Lisa Möbius,Chiara Moltrasio,Caroline Mohn-Haugen,Isabelle Nuss,Emilie Olie,Agnes Pelletier,Zillur Rahman,Davide Rampi,Jonathan Repple,Eugenia Resmini,Julia Schneider,Elena Toffol,for the BIPCOM consortium
DOI: https://doi.org/10.1186/s40345-024-00337-8
2024-05-08
International Journal of Bipolar Disorders
Abstract:BIPCOM aims to (1) identify medical comorbidities in people with bipolar disorder (BD); (2) examine risk factors and clinical profiles of Medical Comorbidities (MC) in this clinical group, with a special focus on Metabolic Syndrome (MetS); (3) develop a Clinical Support Tool (CST) for the personalized management of BD and medical comorbidities.
psychiatry